Medtronic plc (MDT)
Medtronic beats quarterly profit estimates on robust demand for heart devices
Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand for its heart devices and diabetes monitors.
Medtronic: Navigating Tariffs And Chinese VBP Challenges
Medtronic delivered solid Q2 results with beats on revenue and EPS, but now trades at a 5% premium to fair value. Segment growth was led by Cardiovascular and Diabetes, though headwinds from Chinese procurement, tariffs, and regulatory risks persist. FY26 guidance was modestly raised, but forward EPS growth is just 2.5% and revenue guidance remains below consensus.
Ahead of Medtronic (MDT) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Medtronic (MDT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2026.
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
Medtronic (MDT) concluded the recent trading session at $101.72, signifying a -1.15% move from its prior day's close.
Medical device maker Medtronic to buy CathWorks in up to $585 million deal
Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could improve care standards.
Why the Market Dipped But Medtronic (MDT) Gained Today
In the closing of the recent trading day, Medtronic (MDT) stood at $102.96, denoting a +1.94% move from the preceding trading day.
3 Reasons to Add This Medical Technology Stock to Your Portfolio in 2026
Medtronic is divesting a business that's slowing down its margins. The company entered an important market last year.
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic has 'significant firepower' for multiple acquisitions, executives say
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
MDT or ESLOY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
MDT vs. ESLOY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?
